Major Win: Aetna Now Covers PANS and PANDAS Treatments (Including IVIG!)

If you’ve ever spent hours on hold with an insurance company only to be told that your child’s life-altering symptoms are “behavioral” or “experimental,” take a deep breath. We have some news that might actually make you want to do a little happy dance in your kitchen (or at least exhale that breath you’ve been holding since 2019).

In March 2026, Aetna officially updated its medical policy to include PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) and PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections).

Yes, you read that right. A major national insurer has stepped into the light, recognizing these neuroimmune conditions as the medical realities they are. This isn’t just a win for the checkbook; it’s a massive step toward ending the medical gaslighting that has plagued our community for far too long.

Why This is a Big Deal (and Not Just a “Paperwork” Win)

For years, families have been trapped in a cycle: a child wakes up overnight with debilitating OCD, tics, or food restriction, and the medical system responds with a shrug or a prescription for a therapy that doesn’t touch the underlying inflammation. When a doctor finally does identify PANS or PANDAS and recommends treatment, such as IVIG (Intravenous Immunoglobulin), the insurance company often slams the door shut.

Aetna’s move signals a shift in the tide. When major insurers start coding for these conditions, it creates a “domino effect” of validation. It means more multidisciplinary clinics can stay open, more physicians feel confident in their diagnosis, and, most importantly, more children can return to their baseline.

The Nitty-Gritty: What Does Aetna Actually Cover?

Now, because this is insurance, it’s not a “free for all.” There are specific hoops to jump through, but they are hoops based on the PANS Research Consortium diagnostic criteria, which is a huge victory for clinical standardization. If you want to review the full policy language directly, Aetna’s official medical policy is available here: Aetna Clinical Policy Bulletin.

1. The Diagnostic Threshold

To qualify for coverage, the child must meet the classic “sudden and dramatic” onset criteria:

• Sudden onset of OCD or severely restricted food intake (the “overnight” change we know so well).
• Plus at least two of the following neuropsychiatric symptoms:
  • Anxiety (separation anxiety is a big one here).
  • Emotional lability or depression.
  • Irritability, aggression, or severe oppositional behaviors.
  • Developmental or behavioral regression (suddenly acting like a toddler again).
  • Decline in school performance (ADHD-like symptoms, memory issues).
  • Sensory or motor abnormalities (think handwriting changes or “brain fog”).
  • Physical symptoms like sleep disturbances or sudden bedwetting.

2. The Age Window

Aetna typically looks for symptom onset between the age of 3 and puberty. While we know adults can suffer too, this policy is a focused win for the pediatric population.

3. The “Try This First” Clause

Before approving high-level treatments like IVIG, Aetna requires that the child has tried and not responded to systemic corticosteroids. This is a common insurance “step-therapy” requirement, but having it clearly outlined means you and your doctor know exactly what boxes to check to move to the next level of care.

The Importance of Data (Don’t Toss Those Scales!)

One of the most critical parts of the new policy is the requirement for objective documentation. Aetna wants to see the numbers. To get approval, and to keep it for ongoing therapy, you’ll need to provide baseline assessments using standardized tools.

The policy specifically mentions:

• CY-BOCS (Children’s Yale-Brown Obsessive Compulsive Scale)
• CGIS (Clinical Global Impression of Severity)
• PANS Scale (Parent-Rated Pediatric Acute Neuropsychiatric Symptom Scale)

If your doctor isn’t using these yet, now is the time to start. These scales aren’t just extra homework; they are the evidence needed to prove medical necessity and track your child’s progress toward health.

Fighting with Facts

We know that for many of you, the hardest part of this journey hasn’t just been the symptoms, it’s been the feeling that you’re shouting into a void. When an insurance company denies coverage, they aren’t just saying “no” to a bill; they are often implying that your child’s condition isn’t “real” enough to treat.

By aligning their policy with established clinical protocols, Aetna is effectively saying: “We see you. We see your child. This is real.”

This recognition makes it harder for skeptical practitioners to dismiss PANS/PANDAS as a “fad” diagnosis. For families who have been told “it’s just anxiety” or “wait and see,” that kind of policy language can feel like a long-overdue exhale. PACE will continue advocating for clearer protocols, broader access, and a stronger national network of specialized care as more insurers begin to follow suit.

Your “Aetna Prep” Checklist

If you are have Aetna, here is your quick-reference guide to preparing for a treatment request:

• Review the Onset: Document the exact window of “sudden onset” (usually defined as less than one month).
• Check the “Plus Two”: Ensure your medical records clearly list at least two of the secondary symptoms (anxiety, tics, urinary issues, etc.).
• Rule Out the Rest: Ensure your doctor has documented that other potential causes have been investigated and ruled out.
• Corticosteroid Trial: If you haven’t already, discuss a systemic corticosteroid trial with your physician.
• Get the Baseline: Ask your doctor to perform a CY-BOCS or Parent-Rated PANS Scale before treatment starts.

State-by-State Progress Matters Too

Aetna’s March 2026 update is important, but it’s not the only sign of progress. Eighteen states already have laws mandating coverage for PANS/PANDAS diagnosis and treatment, including IVIG. States like Nebraska, Virginia, and Tennessee are part of a growing list showing that families should not have to fight from scratch every time a child needs medically necessary care.

If you want to see the current state-by-state breakdown, including links to policy details, see the list of PANS/PANDAS State Laws.

What’s Next?

This is a massive milestone, but the work isn’t done. We are continuing to advocate for all insurers to follow this lead, and for research that moves us closer to even more targeted, effective therapies.

At The PACE Foundation, we believe that access to care shouldn’t depend on the logo on your insurance card. We are committed to providing free resources to help families and clinicians navigate these complex pathways. For parents and providers who want to dig deeper into the coverage language, Aetna’s full medical policy is also available here: Aetna Clinical Policy Bulletin.

Want to help us keep the momentum going?

• Stay Informed: Sign up for our newsletter for the latest updates on insurance wins and research breakthroughs.
• Support the Mission: Your donations help us continue our advocacy work and provide free education to families. Give today.
• Share Your Story: If you’ve successfully navigated an Aetna claim recently, submit your story to help others in our community!

Together, we are moving the needle. One policy update, one clinical trial, and one child at a time.